Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients

Hypertension

Volumn 30, Issue 1, 1997, Pages 57-63

  Cardillo, Carmine ^a   Kilcoyne, Crescence M ^a   Cannon III, Richard O ^a   Quyyumi, Arshed A ^a   Panza, Julio A ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cholesterol; Free radicals; Hypertension, arterial; Nitric oxide; Xanthine oxidase

Indexed keywords

OXIPURINOL; XANTHINE OXIDASE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030750723     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.57     Document Type: Article

References (39)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
2. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
3. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet. 1992;340:1430-1432.
4. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Role of nitric oxide in the endothelium-dependent vasodilation in hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
5. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
6. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation. 1990;81:1762-1767.
7. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshida A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20:175-180.
8. Reuben GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986; 250:H822-H827.
9. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
10. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
11. Mugge A, Brandes RP, Boger RH, Dwenger A, Bode-Boger S, Kienke S, Frolich JC, Lichtlen PR. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol. 1994;24:994-998.
12. Mugge A, Helwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxation in cholesterol-fed rabbits. Circ Res. 1991;69: 1293-1300.
13. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erithrocuprein (hemocuprein). J Biol Chem. 1969;244: 6049-6055.
14. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA. 1991;88:10045-10048.
15. Friedl HP, Till GO, Ryan US, Ward PA. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 1989;3: 2512-2518.
16. Bulkey GB. Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function. Lancet. 1994; 344:934-936.
17. McKelvey G, Hollwarth E, Glanger N, Engerson D, Landler U, Jones P. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol. 1988;27:G753-G760.
18. Whitney RJ. Measurement of changes in human limb volume by means of a mercury-in-rubber strain gauge. J Physiol (Lond). 1948; 109:5P-6P.
19. Kerslake DM. The effect of application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol (Lond). 1949;108:451-457.
20. Bohme E, Graf H, Schultz G. Effects of sodium nitroprusside and other smooth muscle relaxant on cyclic-GMP formation in smooth muscle and platelets. Adv Cyclic Nucl Res. 1978;9:131-143.
21. Furchgott RF, ·Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature. 1980;288:373-376.
22. Day RO, Miners J, Birkett DJ, Graham GG, Whitehead A. Relationship between plasma oxypurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol. Br J Pharmacol. 1988;26:429-434.
23. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 1995;92:898-903.
24. Steinbrecher UP. Role of superoxide anion in endothelial-cell modification of low-density lipoprotein. Biochem Biophys Acta. 1988; 929:20-30.
25. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344: 160-162.
26. Inoue N, Hirata K, Yamada M, Hamamori Y, Matzuda Y, Akita H, Yokoyama M. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ Res. 1992;71: 1410-1421.
27. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelium-derived relaxing factor in oxidized lipoproteins. J Clin Invest. 1992; 89:10-18.
28. Galle J, Bengen J, Schollmeyer P, Wanner C. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Circulation. 1995;92:1582-1589.
29. Keaney JF Jr, Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest. 1995;95:2520-2529.
30. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332:488-493.
31. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO III, Quyyumi AA, Panza JA. Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol. 1995: 76:1157-1161.
32. Omar BA, Flores SC, McCord JM. superoxide dismutase: pharmacological developments and applications. Adv Pharmacol. 1992;23: 109-161.
33. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anions in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568-H2572.
34. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of bypercholesterolemic patients with L-Arginine. Lancet. 1991;338:1546-1550.
35. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90: 1248-1253.
36. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free-radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension. 1989;13:859-864.
37. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO III, Quyyumi AA, Panza JA. Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertension. 1995;26(part 1):863-868.
38. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
39. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.